The National Health Service (NHS) is set to distribute sepsis sensors to patients, aiming to prevent around 1,000 deaths annually. These sensors, integrated into mobile applications, watches, or bracelets, will enable the early identification of potential sepsis indicators post-hospital discharge. By monitoring vital signs and signaling deteriorating health conditions promptly, the devices are expected to play a crucial role in saving lives.
Medical professionals emphasize the importance of early sepsis intervention, highlighting that delayed treatment escalates the risk of death by up to 8% per hour. Professor Ramani Moonesinghe, Deputy Medical Director of NHS England, stresses the significance of reducing sepsis-related harm through proactive measures over the coming years.
The wearable technology initiative is geared towards empowering individuals to monitor their vital signs at home, allowing for timely intervention in case of any abnormalities. Recognizing the urgency of detecting sepsis symptoms early, the NHS will be trialing these innovative devices to enhance healthcare delivery.
Sepsis, a condition contributing to an estimated 48,000 deaths annually in the UK, poses a substantial public health concern. With sepsis accounting for 4,000 deaths yearly in England alone, the NHS aims to prevent a quarter of these fatalities through improved care practices.
Commonly stemming from bacterial infections, sepsis manifests in adults through various symptoms such as confusion, muscle pain, and breathing difficulties. Additionally, individuals may exhibit skin discoloration, temperature fluctuations, and reduced urine output, signaling a potential sepsis onset.
Minister for patient safety, Preet Gill, underscores the severity of sepsis, emphasizing the need for prompt recognition and response to deterioration signs. Acknowledging the pivotal role of patient and family advocacy, the minister advocates for a patient-centric approach to healthcare to enhance safety and prevent avoidable tragedies.
Several hospitals have already initiated the distribution of wearable technology to at-risk inpatients to enhance sepsis detection capabilities. Notably, cancer patients undergoing CAR T cell therapy at University College London Hospitals are being outfitted with monitoring devices to track vital signs and mitigate potential sepsis risks.
The introduction of wearable technology aligns with the ‘Modern Service Framework’ plan for sepsis, aimed at enhancing patient outcomes and overall healthcare quality. Dr. Ron Daniels, founder of the UK Sepsis Trust, commends this strategic move, foreseeing improved patient safety and outcomes in the battle against sepsis.
For more information on sepsis and its early warning signs, visit nhs.uk/sepsis.
Select Daily Mirror as a ‘Preferred Source’ on Google News for convenient access to the latest news updates.
At Reach and its affiliated entities, the utilization of cookies and similar technologies enables us and our partners to enhance user experience, analyze site usage patterns, and offer personalized advertisements. You have the option to opt out of data sharing by clicking the “Do Not Sell or Share my Data” button at the bottom of our webpage. Please be aware that preferences are browser-specific. By using our website and services, you acknowledge and consent to our use of cookies as described in our Privacy Notice and Terms and Conditions.
